SECsense Logo

Mangaceuticals, Inc. 8-K Report: Key Developments on February 14, 2025

$MGRX
Form 8-K
Filed on: 2025-02-19
Source
Mangaceuticals, Inc. 8-K Report: Key Developments on February 14, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Company Information:
  • Name: Mangaceuticals, Inc.
  • State of Incorporation: Texas (TX)
  • Address: 15110 N. Dallas Parkway, Suite 600, Dallas, TX 75248
  • Phone Number: (214) 242-9619
  • CIK (Central Index Key): 0001938046
  1. SEC Filing Details:
  • Form Type: 8-K
  • Filing Date: February 14, 2025
  • SEC File Number: 001-41615
  • IRS Employer Identification Number: 87-3841292
  1. Financial Information:
  • Common Stock: $0.0001 par value per share
  • Ticker Symbol: MGRX (traded on NASDAQ)
  1. Reporting Context:
  • Reporting Period: The report covers a single day, February 14, 2025.
  • Currency: USD (United States Dollar)
  • Measurement Units: The report mentions shares and USD per share.
  1. Miscellaneous:
  • The XBRL instance references are noted, indicating this is part of a structured data format for financial reporting.

Insights:

  • The filing is a Form 8-K, which typically reports unscheduled material events or corporate changes, indicating that the information may pertain to significant developments within Mangaceuticals, Inc. around the specified date.
  • The company is publicly traded, and the choice of NASDAQ suggests a possibly higher profile and regulatory scrutiny.
  • The low par value of the common stock ($0.0001) may indicate a startup or growth stage company, potentially appealing to investors looking for high-risk, high-reward opportunities.

Overall, this report is essential for stakeholders looking to assess recent developments in Mangaceuticals, Inc., particularly in terms of corporate governance and financial performance on the date indicated.